NOT-AI-25-036: Notice to Rescind NOT-AI-21-037 "Notice of Information: Submission of NIAID Investigator-Initiated Clinical Trials to Appropriate FOAs"

Notice to Rescind NOT-AI-21-037 "Notice of Information: Submission of NIAID Investigator-Initiated Clinical Trials to Appropriate FOAs"

Notice Number:

NOT-AI-25-036

Key Dates

Release Date:

May 21, 2025

Related Announcements

February 25, 2021 - Notice of Information: Submission of NIAID Investigator-Initiated Clinical Trials to Appropriate FOAs. See Notice NOT-AI-21-037.

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this notice is to rescind NOT-AI-21-037 “Notice of Information: Submission of NIAID Investigator-Initiated Clinical Trials to Appropriate FOAs”, effective May 24, 2025.

Inquiries

Please direct all inquiries to:

Martin Gutierrez
Division of Acquired Immunodeficiency Syndrome (DAIDS)
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-292-4844
Email: [email protected]

Ellen Goldmuntz, M.D., Ph.D.
Division of Allergy, Immunology and Transplantation (DAIT)
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3502
Email: [email protected]

DMID IICT Central Contact Mailbox
Division of Microbiology and Infectious Diseases (DMID)
National Institute of Allergy and Infectious Diseases (NIAID)
Email: [email protected]